Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 196

1.

Antisense oligodeoxynucleotides against the MOR-1 clone alter weight and ingestive responses in rats.

Leventhal L, Cole JL, Rossi GC, Pan YX, Pasternak GW, Bodnar RJ.

Brain Res. 1996 May 6;719(1-2):78-84.

PMID:
8782866
2.

Antisense mapping of the MOR-1 opioid receptor clone: modulation of hyperphagia induced by DAMGO.

Leventhal L, Stevens LB, Rossi GC, Pasternak GW, Bodnar RJ.

J Pharmacol Exp Ther. 1997 Sep;282(3):1402-7.

3.

Mercaptoacetate induces feeding through central opioid-mediated mechanisms in rats.

Stein JA, Znamensky V, Baumer F, Rossi GC, Pasternak GW, Bodnar RJ.

Brain Res. 2000 May 12;864(2):240-51.

PMID:
10802031
4.

Morphine-6beta-glucuronide-induced hyperphagia: characterization of opioid action by selective antagonists and antisense mapping in rats.

Leventhal L, Silva RM, Rossi GC, Pasternak GW, Bodnar RJ.

J Pharmacol Exp Ther. 1998 Nov;287(2):538-44.

6.

Beta-endorphin-induced feeding: pharmacological characterization using selective opioid antagonists and antisense probes in rats.

Silva RM, Hadjimarkou MM, Rossi GC, Pasternak GW, Bodnar RJ.

J Pharmacol Exp Ther. 2001 May;297(2):590-6.

7.

Delta and kappa opioid receptor subtypes and ingestion: antagonist and glucoprivic effects.

Yu WZ, Ruegg H, Bodnar RJ.

Pharmacol Biochem Behav. 1997 Mar;56(3):353-61.

PMID:
9077569
8.

mu- and delta-opioid receptor antisense oligodeoxynucleotides antagonize morphine-induced growth hormone secretion in rats.

Idänpään-Heikkilä JJ, Rauhala P, Männistö PT.

Eur J Pharmacol. 1995 Sep 15;284(1-2):227-30.

PMID:
8549632
10.

Blockade of morphine analgesia by an antisense oligodeoxynucleotide against the mu receptor.

Rossi G, Pan YX, Cheng J, Pasternak GW.

Life Sci. 1994;54(21):PL375-9.

PMID:
8196473
11.

Antisense mapping of opioid receptor clones: effects upon 2-deoxy-D-glucose-induced hyperphagia.

Burdick K, Yu WZ, Ragnauth A, Moroz M, Pan YX, Rossi GC, Pasternak GW, Bodnar RJ.

Brain Res. 1998 Jun 1;794(2):359-63.

PMID:
9622675
12.

Antisense mapping of MOR-1 in rats: distinguishing between morphine and morphine-6beta-glucuronide antinociception.

Rossi GC, Leventhal L, Pan YX, Cole J, Su W, Bodnar RJ, Pasternak GW.

J Pharmacol Exp Ther. 1997 Apr;281(1):109-14.

13.
14.

Inhibition of food intake by neuropeptide Y Y5 receptor antisense oligodeoxynucleotides.

Schaffhauser AO, Stricker-Krongrad A, Brunner L, Cumin F, Gerald C, Whitebread S, Criscione L, Hofbauer KG.

Diabetes. 1997 Nov;46(11):1792-8.

PMID:
9356028
16.

The contribution of MOR-1 exons 1-4 to morphine and heroin analgesia and dependence.

Klein G, Rossi GC, Waxman AR, Arout C, Juni A, Inturrisi CE, Kest B.

Neurosci Lett. 2009 Jul 3;457(3):115-9. doi: 10.1016/j.neulet.2009.04.012.

PMID:
19429175
17.

The effect of mu-opioid receptor antisense on morphine potency and antagonist-induced supersensitivity and receptor upregulation.

Shah S, Duttaroy A, Chen BT, Carroll J, Yoburn BC.

Brain Res Bull. 1997;42(6):479-84.

PMID:
9128924
18.

Effects of angiotensinogen antisense oligonucleotides on fluid intake in response to different dipsogenic stimuli in the rat.

Sinnayah P, Kachab E, Haralambidis J, Coghlan JP, McKinley MJ.

Brain Res Mol Brain Res. 1997 Oct 15;50(1-2):43-50.

PMID:
9406916
19.

Dissociation of analgesic and hyperphagic responses following 2-deoxy-D-glucose.

Bodnar RJ, Kramer E, Simone DA, Kirchgessner AL, Scalisi J.

Int J Neurosci. 1983 Nov;21(3-4):225-36.

PMID:
6584411
20.

Morphine and morphine-6beta-glucuronide-induced feeding are differentially reduced by G-protein alpha-subunit antisense probes in rats.

Silva RM, Rossi GC, Mathis JP, Standifer KM, Pasternak GW, Bodnar RJ.

Brain Res. 2000 Sep 8;876(1-2):62-75.

PMID:
10973594

Supplemental Content

Support Center